《Chemmedchem》重点专注发布医学-药学领域的新研究,旨在促进和传播该领域相关的新技术和新知识。鼓励该领域研究者详细地发表他们的高质量实验研究和理论结果。该杂志创刊至今,在医学-药学领域,有较高影响力,对来稿文章质量要求较高,稿件投稿过审难度较大。欢迎广大同领域研究者投稿该杂志。
CiteScore | SJR | SNIP | CiteScore排名 | |||
---|---|---|---|---|---|---|
6.7 | 0.761 | 0.75 | 学科类别 | 分区 | 排名 | 百分位 |
大类:大类:Pharmacology,ToxicologyandPharmaceutics
小类:小类:GeneralPharmacology,ToxicologyandPharmaceutics
|
Q1 | 9/80 | 89% | |||
大类:大类:Pharmacology,ToxicologyandPharmaceutics
小类:小类:OrganicChemistry
|
Q2 | 56/211 | 73% | |||
大类:大类:Pharmacology,ToxicologyandPharmaceutics
小类:小类:Pharmacology
|
Q2 | 98/313 | 68% | |||
大类:大类:Pharmacology,ToxicologyandPharmaceutics
小类:小类:DrugDiscovery
|
Q2 | 53/157 | 66% | |||
大类:大类:Pharmacology,ToxicologyandPharmaceutics
小类:小类:Biochemistry
|
Q2 | 155/438 | 64% | |||
大类:大类:Pharmacology,ToxicologyandPharmaceutics
小类:小类:MolecularMedicine
|
Q2 | 70/178 | 60% |
按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
---|---|---|---|---|
学科:CHEMISTRY, MEDICINAL | SCIE | Q2 | 31 / 72 | 57.6% |
学科:PHARMACOLOGY & PHARMACY | SCIE | Q2 | 94 / 354 | 73.6% |
按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
---|---|---|---|---|
学科:CHEMISTRY, MEDICINAL | SCIE | Q2 | 30 / 72 | 59.03% |
学科:PHARMACOLOGY & PHARMACY | SCIE | Q2 | 112 / 354 | 68.5% |
文章名称
引用次数
Design of Modular G-quadruplex Ligands
28
Covalent Inhibition in Drug Discovery
27
Benzofuran and Indole: Promising Scaffolds for Drug Development in Alzheimers Disease
25
Employing Photoredox Catalysis for DNA-Encoded Chemistry: Decarboxylative Alkylation of alpha-Amino Acids
24
Recent Advances in the Development of Indazole-based Anticancer Agents
20
TAS-120 Cancer Target Binding: Defining Reactivity and Revealing the First Fibroblast Growth Factor Receptor 1 (FGFR1) Irreversible Structure
18
Hollow Mesoporous Silica@Metal-Organic Framework and Applications for pH-Responsive Drug Delivery
14
The Curtius Rearrangement: Applications in Modern Drug Discovery and Medicinal Chemistry
13
Monosaccharide Derivatives with Low-Nanomolar Lectin Affinity and High Selectivity Based on Combined Fluorine-Amide, Phenyl-Arginine, Sulfur-pi, and Halogen Bond Interactions
13
Discovery and Mechanistic Elucidation of a Class of Protein Disulfide Isomerase Inhibitors for the Treatment of Glioblastoma
13
国家/地区
发文量
TUSA
201
TGERMANY (FED REP GER)
173
TItaly
132
TCHINA MAINLAND
85
TEngland
79
TFrance
52
TSwitzerland
52
TIndia
44
TAustralia
40
TSpain
36





